An expanded access record providing Plasminogen (Human) in Hypoplasminogenemia, sponsored by Prometic Biotherapeutics, Inc.. No longer available. Open to participants aged 16 Months and older. Per ClinicalTrials.gov, last updated 2020-04-24.
Sponsored by Prometic Biotherapeutics, Inc. · Expanded access
These are single-patient studies with repeat-dose administration of ProMetic Plasminogen IV infusion in one adult and one child with hypoplasminogenemia. These patients are under treatment to address wound healing and obstructions.
Exclusion Criteria:
No study locations are listed for this record.
Expanded access is arranged between your doctor and the company. Ask your care team to contact the provider listed on this record.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Prometic Biotherapeutics, Inc.